Tag Archives: NASDAQ:ANTH

Anthera Pharmaceuticals (NASDAQ:ANTH) Net Loss Narrows in Fiscal Fourth Quarter

Anthera Pharmaceuticals Inc (NASDAQ:ANTH) announced on Thursday that net loss in fiscal fourth-quarter was $8.9 million or $0.11 a share, narrower than $29.2 million or $0.71 a share in the similar period a year ago.

Thomson Reuters 7 analysts’ survey …

Posted in Healthcare, Main Post | Tagged , , , , , , , , , , , | Comments Off

Humana Inc.’s (NYSE:HUM) Profit Slips on Inflated Coverage Costs – HUM, LLY, ANTH, RMTI, CTIC, ARNA, LLY,

Humana Inc.’s (NYSE:HUM) fourth-quarter earnings plunged down 3.5% as inflated coverage costs covered the health-care firm’s revenue growth from hiked membership. Past month, Humana finished its approximately $850 million takeover of Metropolitan Health Networks Inc., a medical-services supplier mainly operating …

Posted in Healthcare, Latest Headlines | Tagged , , , , , , , , , , , , , , , , , | Comments Off

Morgan Stanley (MS) Shatter Merck (NYSE:MRK) Stock Rating after Quarterly Results – MRK, GALE, TEVA, ANTH, JNJ, HEB, BMY, GSK, NVS

Merck & Co., Inc (NYSE:MRK) stock rationing was lower to market perform by Lee rink Swann while Morgan Stanley shatters their rationing to underweight.

Shares of second biggest drug maker in US plunged on Monday in early trading session as …

Posted in Healthcare, Latest Headlines | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off

Covidien PLC (NYSE:COV) Superior Sales Masked by Split Off Costs, Outlook Raised – COV, BDX, BCR, BMY, PFE, JNJ, ANTH, ABT, KERX

Covidien PLC (NYSE:COV) witnessed a 0.2% drop in fiscal first-quarter earnings as costs to divide the health-care products firm weighed over its bubbly sales.

The firm also lifted its fiscal 2013 sales target, now anticipating a 5% to 8% hike, …

Posted in Healthcare, Latest Headlines | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off

Amarin Corp. (NASDAQ:AMRN)Risks with Vascepa Launch Plunges Stock – AMRN, MRK, PDLI, PPHM, ANTH, BMY, ARNA, CHTP

Shares of Amarin Corp. (NASDAQ:AMRN)plunged 17% to $9.87 per share in early trading hours on Friday following the drug manufacturer took out a credit line of $100 million as it sets up for the release of its Vascepa drug to …

Posted in Healthcare, Latest Headlines | Tagged , , , , , , , , , , , , , , , , , , , , , , , | Comments Off

Johnson & Johnson (JNJ) Lowers 2012 Guidance; Profit Smashed by Currency Rates

Johnson & Johnson (NYSE:JNJ), the world’s largest manufacturer of health-care items, trimmed its full-year profit estimation on critical foreign-exchange rates.

J&J’s 2Q net income declined almost 49 percent to $1.4 billion, or 50 cents per share, on takeover expense, …

Posted in Healthcare, Latest Headlines | Tagged , , , , , , , , , , , , , , , , , , | Comments Off